Skip to main content
OpenTrials
Completed

NCT Number: NCT00110552

Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients

The purpose of this study is to determine the effectiveness of the herb sage in improving the mental function of individuals with Alzheimer's disease.

Study hypothesis: The administration of sage will improve cognitive function in patients with mild Alzheimer's disease.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Oregon Health and Science University

Portland, Oregon, 97239, United States

About this study

The herb sage has been shown to enhance memory and mental function in healthy, young adults. However, studies assessing the herb's effectiveness in older adults with symptoms of Alzheimer's disease are limited. This study will determine the effect of sage extract on the cognitive function of patients with mild Alzheimer's disease.

This study will last 6 weeks and will comprise 4 study visits, approximately 10 days apart. Participants will be randomly assigned to receive either sage pills or no treatment during each 10-day period. The treatment assignments will be switched in 10-day intervals, so that during the course of the study, each participant will undergo two periods of sage treatment and two periods without treatment. At each study visit, participants will undergo cognitive testing, including tests to determine attention, memory, and visual cognition. Participants will also undergo an electroencephalogram (EEG) and an electrocardiogram (ECG) at each visit.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of mild Alzheimer's disease
  • Partner, friend, child, spouse, or relative willing to accompany participants to all study visits, provide informed consent, monitor participants' pill-taking, and communicate changes in participants' health during the study

Exclusion criteria

  • Significant medical illness other than Alzheimer's disease

Treatment and study plan

Salvia officinalis (sage)

Drug

oral dosage

Other names: sage

Primary outcomes

  1. Cognitive function

    Time frame: 8 weeks

Secondary outcomes

  1. Stress

    Time frame: 8 weeks

  2. cognitive electrophysiology

    Time frame: 8 weeks

Sponsors and collaborators

Lead sponsor

Oregon Health and Science University

Other

Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

Registry information

Official study title

Effects of a Cognitive Enhancer on Memory and Cognitive Performance

Important dates

Study start
2005
Primary completion
2012
Study completion
2014
First posted
May 11, 2005
Registry last updated
Oct 29, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.